Displaying 21 - 40 of 1638
FTC Takes Action to Protect Americans from Higher Drug Costs in Aurobindo, Lannett Deal
Aurobindo-Lannett, In the Matter of
The FTC is requiring Aurobindo Pharma Limited to divest four different generic drug products to complete its $250 million acquisition of Lannett Company Inc.
WPATH, FTC v.
The Federal Trade Commission, along with Alaska, Iowa, Nebraska and Texas, today filed a lawsuit against the World Professional Association for Transgender Health (WPATH), alleging the organization has provided the means for medical providers to make false and unsubstantiated claims to parents in order to sell pediatric medical transition services.
FTC, States Sue World Professional Association for Transgender Health Over Deceptive Claims Regarding the Treatment of Children
Ascension Health Alliance; Analysis of Proposed Agreement Containing Consent Orders To Aid Public Comment
FTC Finalizes Consent Order in Sevita, BrightSpring Acquisition
Centerbridge Seaport Acquisition Fund/BrightSpring Health Services, Inc.
The Federal Trade Commission took action to protect Americans with intellectual and developmental disabilities and their families by requiring Sevita Health (Sevita) to divest more than 100 healthcare facilities to resolve antitrust concerns surrounding its proposed $835 million acquisition of BrightSpring Health Services, Inc.’s (BrightSpring) community living business.
Under the FTC’s proposed consent order, Sevita will be required to divest 128 intermediate care facilities (ICFs), which provide IDD services, and other assets such as day-training programs. The divested facilities—which are in Indiana, Louisiana, and Texas—will be acquired by Dungarvin Group, Inc. (Dungarvin), an experienced and well-regarded operator of ICFs.
On June 10, 2026, the FTC finalized the consent order in this matter.
FTC Requires Divestiture of Ambulatory Surgery Centers to Protect Patients from Anticompetitive Effects of Ascension Health-AmSurg Deal
Ascension/AMSURG, In the Matter of
The Federal Trade Commission took action to protect American patients from higher outpatient surgery costs by requiring national nonprofit health system Ascension Health Alliance (Ascension) to divest several surgery center facilities to complete its proposed $3.9 billion acquisition of AmSurg LLC.
FTC Charts Path to Restore Competition in Texas Anesthesia Markets in USAP Litigation
U.S. Anesthesia Partners, Inc., FTC v.
Innovative Partners, FTC v.
In April 2026, at the FTC’s request, a U.S. district court in Florida temporarily halted a nationwide operation that allegedly impersonates the government and large insurance carriers to deceive consumers seeking health insurance into buying supposedly comprehensive PPO plans that do not offer the coverage they seek.
FTC Sues to Stop Deceptive Health Care Scheme
FTC Staff Warn Tennessee Legislature of Risks to Patients if Ballad Health COPA Expires and Support Proposed Repeal of Certificate of Need Requirements
FTC Chairman Andrew N. Ferguson Launches Healthcare Task Force
FTC Stops Proposed Merger of Leading Cataract-Surgery Device Makers
Mercury Marketing LLC, FTC v.
The FTC filed a complaint alleging that Mercury Marketing, LLC, and other defendants impersonated substance use disorder treatment clinics in Google search ads to deceptively route consumers trying to call those clinics to defendant clinics.
Express Scripts, Inc., et al.; Analysis of Agreement Containing Consent Order To Aid Public Comment
Displaying 21 - 40 of 1638